ACI 21st Annual Paragraph IV Conference

Axinn partners Matthew Murphy and Aziz Burgy will speak at American Conference Institute's Paragraph IV Disputes Conference, being held April 29-30 in New York. 

On April 29, Matthew will speak on the "Determining What’s Listable in the Orange Book: What Can We Glean from the Latest FTC Activity on Drug Device Combinations, and Counterclaims?" panel. Panelists will discuss: 

• The rise of FTC scrutiny of Orange Book patents;

• Patent portfolios for potential FTC targets;

• Preparing for delisting as a strategy in the district courts following the decision in the Teva v. Amneal case and more. 

On April 30, Aziz will speak on " The Next Frontier for Drug Discovery and Patent Law: A Hatch-Waxman Practitioner’s Guide to Artificial Intelligence." Panelists will discuss: 

• How AI can assist with drug discovery and across the life sciences sector;

• USPTO inventorship guidance on AI-assisted inventions;

• The potential impact of Algorithmic prior art on eligibility and litigation and more.